Cargando…

Statins for primary cardiovascular prevention in the elderly

The elderly population is increasing worldwide, with subjects > 65 years of age constituting the fastest-growing age group. Furthermore, the elderly face the greatest risk and burden of cardiovascular disease mortality and morbidity. Although elderly patients, particularly those older > 75, ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedro-Botet, Juan, Climent, Elisenda, Chillarón, Juan J, Toro, Rocio, Benaiges, David, Flores-Le Roux, Juana A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554788/ https://www.ncbi.nlm.nih.gov/pubmed/26345308 http://dx.doi.org/10.11909/j.issn.1671-5411.2015.04.016

Ejemplares similares

Hydrophilic or Lipophilic Statins?
por: Climent, Elisenda, et al.
Publicado: (2021)

Telehealth model versus in-person standard care for persons with type 1 diabetes treated with multiple daily injections: an open-label randomized controlled trial
por: Ballesta, Sílvia, et al.
Publicado: (2023)

Familial Hypercholesterolemia: Do HDL Play a Role?
por: Pedro-Botet, Juan, et al.
Publicado: (2021)

Bariatric Surgery and Hypertension
por: Climent, Elisenda, et al.
Publicado: (2021)

Seven-year mortality in heart failure patients with undiagnosed diabetes: an observational study
por: Flores-Le Roux, Juana A, et al.
Publicado: (2011)

Bariatric surgery and LDL cholesterol (BASALTO) trial study protocol: randomised controlled study evaluating the effect of gastric bypass versus sleeve gastrectomy on high LDL cholesterol
por: Benaiges, David, et al.
Publicado: (2020)

Efficacy of treatment for hyperglycemic crisis in elderly diabetic patients in a day hospital
por: Benaiges, D, et al.
Publicado: (2014)

Additional Metabolic Effects of Bariatric Surgery in Patients with a Poor Mid-Term Weight Loss Response: A 5-Year Follow-Up Study
por: Benaiges, David, et al.
Publicado: (2020)

The Forgotten Gastrointestinal Tract in COVID-19 Infection
por: Pedro-Botet, Juan, et al.
Publicado: (2020)

Trends in prevalence of pre-existing diabetes and perinatal outcomes: a large, population-based study in Catalonia, Spain, 2006–2015
por: Gortazar, Lucia, et al.
Publicado: (2020)

Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Heart Failure: A Prospective Study
por: Carrera, Mª José, et al.
Publicado: (2021)

Trends in Prevalence of Diabetes among Twin Pregnancies and Perinatal Outcomes in Catalonia between 2006 and 2015: The DIAGESTCAT Study
por: Gortazar, Lucia, et al.
Publicado: (2021)

Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
por: Climent, Elisenda, et al.
Publicado: (2017)

Validity and Applicability of the Global Leadership Initiative on Malnutrition (GLIM) Criteria in Patients Hospitalized for Acute Medical Conditions
por: Fontane, Laia, et al.
Publicado: (2023)

Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients
por: Strandberg, Timo E.
Publicado: (2019)

Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins
por: Marco-Benedí, Victoria, et al.
Publicado: (2021)

Effects of Statins for Primary Prevention in the Elderly: Recent Evidence
por: Kim, Kyu, et al.
Publicado: (2020)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

Statin for the Primary Prevention of Cardiovascular Disease in Patients with Diabetes Mellitus
por: Koo, Bo Kyung
Publicado: (2014)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?
por: Kumar, Arun H. S.
Publicado: (2016)

Primary prevention with statins in cardiovascular diseases: A Saudi Arabian perspective
por: Mahmood, D., et al.
Publicado: (2015)

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease
por: Hope, Holly F., et al.
Publicado: (2019)

Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury
por: Coste, Joël, et al.
Publicado: (2019)

Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic
por: Malo, Sara, et al.
Publicado: (2022)

Randomized Clinical Trial: A Normocaloric Low-Fiber Diet the Day Before Colonoscopy Is the Most Effective Approach to Bowel Preparation in Colorectal Cancer Screening Colonoscopy
por: Alvarez-Gonzalez, Marco A., et al.
Publicado: (2019)

The use of statins in primary prevention
por: Rosian, Ingrid, et al.
Publicado: (2006)

Formal comment on “Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease”
por: Diamond, David M., et al.
Publicado: (2019)

Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis
por: Fleetcroft, Robert, et al.
Publicado: (2014)

Statins for primary cardiovascular disease prevention among people with HIV: emergent directions
por: Fitch, Kathleen V., et al.
Publicado: (2022)

Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
por: Clough, Jeffrey D., et al.
Publicado: (2019)

Aspirin for the primary prevention of cardiovascular disease in the elderly
por: O’Sullivan, Jack W
Publicado: (2019)

The JUPITER study: statins for the primary prevention of cardiovascular events in patients with inflammatory rheumatic diseases?
por: Ward, Michael M
Publicado: (2009)

Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention
por: Millán, Jesús, et al.
Publicado: (2009)

Statins in primary prevention: is the enthusiasm justified?
por: Chopra, Arun K., et al.
Publicado: (2020)

Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study
por: Millán Núñez-Cortés, Jesús, et al.
Publicado: (2016)

Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
por: Kohli-Lynch, Ciaran N., et al.
Publicado: (2022)

Risk‐benefit analysis of use of statins for primary prevention of cardiovascular disease in subjects without diabetes
por: Chan, Juliana CN
Publicado: (2013)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention()
por: Wang, Frances M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l18tk2h7klv9ksli1reuamcqsr